Leading health journalists slam pharma's 'terrible' image

The pharma industry has a 'terrible' image and media coverage is too focused on conflicts over expensive drugs, leading health journalists said this week.

Outspoken: BBC Scotland’s health correspondent Eleanor Bradford
Outspoken: BBC Scotland’s health correspondent Eleanor Bradford

Speaking at the PRWeek Pharma Communications Conference on Wednesday, BBC Scotland’s health correspondent Eleanor Bradford said: ‘The problem that you have is the public is sceptical – pharma has connotations of big business making loads of money, basically. What they don’t think of is people spending a whole lifetime to develop a drug to prevent a disease.

‘It would be nice to reflect more on this and less on whether an expensive drug is justifiable.’

On breast cancer drug herceptin, which was labelled a ‘wonder drug’ by some parts of the media that successfully campaigned for NICE to overturn its original decision not to recommend it for the NHS, she said: 'The media learned a lot from herceptin. It wasn’t quite as good as the media portrayed.'

Kevin Grogan, World News online editor, Pharma Times, said the industry’s reputation as a whole was 'terrible'.

He said: ‘The industry has been very arrogant. Pharma is a dirty word and that will take a long time to get over. Companies are doing great work but it has a reputational issue.’

Rebecca Creamer, commissioning editor of the Health Service Journal, said: ‘I think in trade press it is getting better, but the industry has baggage in the national press.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in